On Market View Minutes, Michelle Martin looks at the next generation of potential COVID-19 treatment and the companies that stand to gain from producing the pill namely, Merck, Pfizer and Atea Pharmaceuticals. 

<p>On Market View Minutes, Michelle Martin looks at the next generation of potential COVID-19 treatment and the companies that stand to gain from producing the pill namely, Merck, Pfizer and Atea Pharmaceuticals.&nbsp;</p>

Advertisement